Show simple item record

2021-05-14Zeitschriftenartikel DOI: 10.25646/8761
Disease surveillance for the COVID-19 era: time for bold changes
dc.contributor.authorMorgan, Oliver W
dc.contributor.authorAguilera, Ximena
dc.contributor.authorAmmon, Andrea
dc.contributor.authorAmuasi, John
dc.contributor.authorFall, Ibrahima Socé
dc.contributor.authorFrieden, Tom
dc.contributor.authorHeymann, David
dc.contributor.authorIhekweazu, Chikwe
dc.contributor.authorJeong, Eun-kyeong
dc.contributor.authorLeung, Gabriel M
dc.contributor.authorMahon, Barbara
dc.contributor.authorNkengasong, John
dc.contributor.authorQamar, Farah Naz
dc.contributor.authorSchuchat, Anne
dc.contributor.authorWieler, Lothar H
dc.contributor.authorDowell, Scott F
dc.date.accessioned2021-07-07T06:40:22Z
dc.date.available2021-07-07T06:40:22Z
dc.date.issued2021-05-14none
dc.identifier.other10.1016/S0140-6736(21)01096-5
dc.identifier.urihttp://edoc.rki.de/176904/8491
dc.description.abstractThe COVID-19 pandemic has exposed weaknesses in disease surveillance in nearly all countries. Early identification of COVID-19 cases and clusters for rapid containment was hampered by inadequate diagnostic capacity, insufficient contact tracing, fragmented data systems, incomplete data insights for public health responders, and suboptimal governance of all these elements. Once SARS-CoV-2 became widespread, interventions to control community transmission were undermined by weak surveillance of cases and insufficient national capacity to integrate data for timely adjustment of public health measures.1, 2 Although some countries had little or no reliable data, others did not share data consistently with their own populations and with WHO and other multilateral agencies. The emergence of SARS-CoV-2 variants has highlighted inadequate national pathogen genomic sequencing capacities in many countries and led to calls for expanded virus sequencing. However, sequencing without epidemiological and clinical surveillance data is insufficient to show whether new SARS-CoV-2 variants are more transmissible, more lethal, or more capable of evading immunity, including vaccine-induced immunity.eng
dc.language.isoengnone
dc.publisherRobert Koch-Institut
dc.subject.ddc610 Medizin und Gesundheitnone
dc.titleDisease surveillance for the COVID-19 era: time for bold changesnone
dc.typearticle
dc.identifier.urnurn:nbn:de:kobv:0257-176904/8491-3
dc.identifier.doihttp://dx.doi.org/10.25646/8761
dc.type.versionpublishedVersionnone
local.edoc.container-titleThe Lancetnone
local.edoc.container-issn0140-6736none
local.edoc.pages3none
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttps://www.sciencedirect.com/science/article/pii/S0140673621010965none
local.edoc.container-publisher-nameElseviernone
local.edoc.container-volume397none
local.edoc.container-issue10292none
local.edoc.rki-departmentInstitutsleitungnone
dc.description.versionPeer Reviewednone

Show simple item record